CellumedLtd Past Earnings Performance
Past criteria checks 0/6
CellumedLtd has been growing earnings at an average annual rate of 1%, while the Medical Equipment industry saw earnings growing at 17.7% annually. Revenues have been growing at an average rate of 25.3% per year.
Key information
1.0%
Earnings growth rate
24.0%
EPS growth rate
Medical Equipment Industry Growth | 22.7% |
Revenue growth rate | 25.3% |
Return on equity | -99.8% |
Net Margin | -27.0% |
Last Earnings Update | 30 Jun 2024 |
Revenue & Expenses Breakdown
How CellumedLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 111,867 | -30,238 | 25,002 | 989 |
31 Mar 24 | 102,157 | -33,351 | 26,400 | 1,423 |
31 Dec 23 | 95,553 | -37,280 | 26,201 | 1,506 |
30 Sep 23 | 95,474 | -20,081 | 16,908 | 1,681 |
30 Jun 23 | 101,425 | -19,700 | 16,702 | 1,673 |
31 Mar 23 | 112,943 | -13,167 | 15,031 | 1,326 |
31 Dec 22 | 122,085 | -5,368 | 15,048 | 1,523 |
30 Sep 22 | 126,015 | 7,460 | 12,099 | 1,542 |
30 Jun 22 | 121,361 | 11,339 | 8,732 | 1,469 |
31 Mar 22 | 109,832 | 10,257 | 8,111 | 1,351 |
31 Dec 21 | 99,918 | 8,010 | 7,087 | 1,170 |
30 Sep 21 | 84,564 | 2,931 | 7,968 | 599 |
30 Jun 21 | 82,010 | 124 | 10,973 | 615 |
31 Mar 21 | 77,548 | -38 | 10,216 | 1,216 |
31 Dec 20 | 73,188 | -1,078 | 10,576 | 783 |
30 Sep 20 | 66,694 | -31,951 | 9,716 | 985 |
30 Jun 20 | 45,315 | -34,397 | 9,160 | 893 |
31 Mar 20 | 29,904 | -35,762 | 9,219 | 470 |
31 Dec 19 | 17,921 | -36,422 | 8,980 | 642 |
30 Sep 19 | 10,983 | -17,881 | 9,454 | 492 |
30 Jun 19 | 10,156 | -15,428 | 8,011 | 342 |
31 Mar 19 | 9,311 | -7,012 | 10,203 | 193 |
31 Dec 18 | 9,915 | -7,890 | 10,152 | 205 |
30 Sep 18 | 13,782 | 969 | 7,697 | 716 |
30 Jun 18 | 15,763 | -783 | 9,571 | 725 |
31 Mar 18 | 18,279 | -8,541 | 6,987 | 553 |
31 Dec 17 | 19,904 | -6,302 | 6,312 | 655 |
30 Sep 17 | 16,388 | -11,050 | 13,992 | 650 |
30 Jun 17 | 14,696 | -10,624 | 13,479 | 268 |
31 Mar 17 | 12,076 | -34,743 | 13,887 | 729 |
31 Dec 16 | 9,814 | -36,588 | 14,081 | 564 |
30 Sep 16 | 12,815 | -35,616 | 9,353 | 153 |
30 Jun 16 | 12,563 | -38,046 | 10,486 | 316 |
31 Mar 16 | 15,415 | -13,630 | 10,798 | 153 |
31 Dec 15 | 17,731 | -11,345 | 10,453 | 153 |
30 Sep 15 | 14,764 | -19,493 | 15,464 | 5 |
30 Jun 15 | 17,681 | -15,940 | 14,627 | 187 |
31 Mar 15 | 20,532 | -13,724 | 14,735 | 5 |
31 Dec 14 | 20,735 | -14,913 | 15,753 | 5 |
30 Sep 14 | 28,948 | -2,193 | 10,363 | 0 |
30 Jun 14 | 29,324 | -1,983 | 10,270 | 0 |
31 Mar 14 | 27,159 | -3,355 | 10,696 | 0 |
31 Dec 13 | 30,665 | -2,250 | 10,607 | 0 |
Quality Earnings: A049180 is currently unprofitable.
Growing Profit Margin: A049180 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A049180 is unprofitable, but has reduced losses over the past 5 years at a rate of 1% per year.
Accelerating Growth: Unable to compare A049180's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A049180 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.6%).
Return on Equity
High ROE: A049180 has a negative Return on Equity (-99.76%), as it is currently unprofitable.